UK Regulatory Changes During a Brexit Transition Period – the Government Explains All

Executive Summary Guidance documents on the regulation of medicines in the UK during a Brexit transition period have been published by the government, covering areas like batch release, drug approvals, and the role of the UK MHRA in the EU regulatory system. Register for our free email digests:

Executive Summary

Guidance documents on the regulation of medicines in the UK during a Brexit transition period have been published by the government, covering areas like batch release, drug approvals, and the role of the UK MHRA in the EU regulatory system.

Register for our free email digests:

Source: pink.pharmaintelligence.informa.com